Sixfold Bioscience
Business Services · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
84 Hub, London, Greater London, W12 0BZ,...Website
sixfold.bioRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Sixfold Bioscience
Sixfold Bioscience is a venture-backed preclinical-stage biotechnology company based at the Innovation and Translation Hub in White City, London. Sixfold develops nucleic acid-based drug delivery systems, with a current focus on Cell & Gene therapeutics such as short interfering RNA for gene silencing and messenger RNA for gene expression.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sixfold Bioscience your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Sixfold Bioscience has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Sixfold Bioscience recently announced quarterly report
Check out if Sixfold Bioscience is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Sixfold Bioscience, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Sixfold Bioscience
Product Launch: Get notified when Sixfold Bioscience launches new products
Website visits: Recent activity has been detected on your website
Click to see if Sixfold Bioscience had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Sixfold Bioscience has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Sixfold Bioscience
Compare insights from companies similar to Sixfold Bioscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Sixfold Bioscience
<$5M
11-50
Private
$10.5M
2017
N/A
Company Profile Activity
Activity Insights
Sixfold Bioscience is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Sixfold Bioscience is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Sixfold Bioscience.
Sixfold Bioscience financials insights
Gather financial insights about Sixfold Bioscience, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Angel/Seed
$10.5M
Sixfold Bioscience Tech Stack
A closer look at the technologies used by Sixfold Bioscience
Sixfold Bioscience News & Media
Sixfold Bioscience Joins Wellcome Leap R3 Funded Program to Boost RNA Readiness and Response
LONDON, Jan. 19, 2022 /PRNewswire/ -- Sixfold Bioscience, the RNA Architects, today announced their selection for the Wellcome Leap R3: RNA Readiness + Response Program. Co-funded with CEPI, this global initiative includes leading organisations worldwide, forming an RNA biofoundry for...Sixfold Bioscience Completes $10.5M USD (£7.8M GBP) Seed Financing
LONDON--(BUSINESS WIRE)--Sixfold Bioscience, a company designing RNA therapeutic delivery systems, announced it has raised $10.5 million USD in its seed funding round.
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sixfold Bioscience
Sign Up For FreeTo access detailed company insights
Sixfold Bioscience is a venture-backed preclinical-stage biotechnology company based at the Innovation and Translation Hub in White City, London. Sixfold develops nucleic acid-based drug delivery systems, with a current focus on Cell & Gene therapeutics such as short interfering RNA for gene silencing and messenger RNA for gene expression.... Read More
